Global Intravenous (IV) Cannula Market
Global Intravenous (IV) Cannula Market

Intravenous (IV) Cannula Comprehensive Study by Application (Medicine Administration, Intravenous Fluid Administration, Others), End-users (Hospital, Clinic, Others), Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Others), Size (Orange (14G), Grey (16G), Green (18G), Pink (20G), Blue (22G), Yellow (24G), Violet (26G)), Material (Plastic, Metal, Silicone) Players and Region - Global Market Outlook to 2025

Intravenous (IV) Cannula Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

May 2020 Edition 212 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Intravenous (IV) cannula is a very small, flexible tube which is placed into one of the veins, usually in the back of the hand or in the arm used intravenous administration of medication or infusions. It is generally made of polyurethane thermoplastic material which is highly biocompatible, enabling the cannula to remain in place for a prolonged period. There are various types of cannula sizes used in hospitals. Its size varies according to its types and uses.

The market study is being classified, by Application (Medicine Administration, Intravenous Fluid Administration and Others) and major geographies with country level break-up.

Boston Scientific Corporation (United States), Teleflex Incorporated (United States), CONMED Corporation (United States), Sorin Group (Italy), Edward Lifescience (United States), Medtronic plc (Ireland), Terumo Corporation (Japan), Smith & Nephew plc (United Kingdom), Smiths Medical, Inc. (United States) and MAQUET Holding B.V. & Co. KG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Armstrong Medical Ltd (United Kingdom) and Omex Medical Technology (India).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Intravenous (IV) Cannula market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Intravenous (IV) Cannula market by Type, Application and Region.

On the basis of geography, the market of Intravenous (IV) Cannula has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Number of Surgeries and Minimally Invasive Procedures
  • Growth in the Healthcare Infrastructure in Developing Countries
  • Various Applications of Intravenous Cannula

Market Trend
  • Increased Demand for Medical Supplies Worldwide
  • Increased Prevalence of Cardiac Diseases

Restraints
  • Complications Associated with Intravenous Cannula

Opportunities
  • Growth in the Health Care Industry Worldwide
  • Increasing Number of COVID-19 Patients Worldwide results in Hospitalization of the Patients

Challenges
  • Increasing Competition in the Market


Market Leaders and their expansionary development strategies
In August 2019, Boston Scientific Corporation has announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.



Key Target Audience
Intravenous (IV) Cannula Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies and End-users

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Application
  • Medicine Administration
  • Intravenous Fluid Administration
  • Others
By End-users
  • Hospital
  • Clinic
  • Others

By Distribution Channel
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

By Size
  • Orange (14G)
  • Grey (16G)
  • Green (18G)
  • Pink (20G)
  • Blue (22G)
  • Yellow (24G)
  • Violet (26G)

By Material
  • Plastic
  • Metal
  • Silicone

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Number of Surgeries and Minimally Invasive Procedures
      • 3.2.2. Growth in the Healthcare Infrastructure in Developing Countries
      • 3.2.3. Various Applications of Intravenous Cannula
    • 3.3. Market Challenges
      • 3.3.1. Increasing Competition in the Market
    • 3.4. Market Trends
      • 3.4.1. Increased Demand for Medical Supplies Worldwide
      • 3.4.2. Increased Prevalence of Cardiac Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Intravenous (IV) Cannula, by Application, End-users, Distribution Channel, Size, Material and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Intravenous (IV) Cannula (Value)
      • 5.2.1. Global Intravenous (IV) Cannula by: Application (Value)
        • 5.2.1.1. Medicine Administration
        • 5.2.1.2. Intravenous Fluid Administration
        • 5.2.1.3. Others
      • 5.2.2. Global Intravenous (IV) Cannula by: End-users (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Others
      • 5.2.3. Global Intravenous (IV) Cannula by: Distribution Channel (Value)
        • 5.2.3.1. Online Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Hospital Pharmacies
        • 5.2.3.4. Others
      • 5.2.4. Global Intravenous (IV) Cannula by: Size (Value)
        • 5.2.4.1. Orange (14G)
        • 5.2.4.2. Grey (16G)
        • 5.2.4.3. Green (18G)
        • 5.2.4.4. Pink (20G)
        • 5.2.4.5. Blue (22G)
        • 5.2.4.6. Yellow (24G)
        • 5.2.4.7. Violet (26G)
      • 5.2.5. Global Intravenous (IV) Cannula by: Material (Value)
        • 5.2.5.1. Plastic
        • 5.2.5.2. Metal
        • 5.2.5.3. Silicone
      • 5.2.6. Global Intravenous (IV) Cannula Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Intravenous (IV) Cannula (Volume)
      • 5.3.1. Global Intravenous (IV) Cannula by: Application (Volume)
        • 5.3.1.1. Medicine Administration
        • 5.3.1.2. Intravenous Fluid Administration
        • 5.3.1.3. Others
      • 5.3.2. Global Intravenous (IV) Cannula by: End-users (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Clinic
        • 5.3.2.3. Others
      • 5.3.3. Global Intravenous (IV) Cannula by: Distribution Channel (Volume)
        • 5.3.3.1. Online Pharmacies
        • 5.3.3.2. Retail Pharmacies
        • 5.3.3.3. Hospital Pharmacies
        • 5.3.3.4. Others
      • 5.3.4. Global Intravenous (IV) Cannula by: Size (Volume)
        • 5.3.4.1. Orange (14G)
        • 5.3.4.2. Grey (16G)
        • 5.3.4.3. Green (18G)
        • 5.3.4.4. Pink (20G)
        • 5.3.4.5. Blue (22G)
        • 5.3.4.6. Yellow (24G)
        • 5.3.4.7. Violet (26G)
      • 5.3.5. Global Intravenous (IV) Cannula by: Material (Volume)
        • 5.3.5.1. Plastic
        • 5.3.5.2. Metal
        • 5.3.5.3. Silicone
      • 5.3.6. Global Intravenous (IV) Cannula Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Intravenous (IV) Cannula (Price)
  • 6. Intravenous (IV) Cannula: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teleflex Incorporated (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CONMED Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sorin Group (Italy)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Edward Lifescience (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic plc (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Terumo Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smith & Nephew plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Smiths Medical, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. MAQUET Holding B.V. & Co. KG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Intravenous (IV) Cannula Sale, by Application, End-users, Distribution Channel, Size, Material and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Intravenous (IV) Cannula (Value)
      • 7.2.1. Global Intravenous (IV) Cannula by: Application (Value)
        • 7.2.1.1. Medicine Administration
        • 7.2.1.2. Intravenous Fluid Administration
        • 7.2.1.3. Others
      • 7.2.2. Global Intravenous (IV) Cannula by: End-users (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Others
      • 7.2.3. Global Intravenous (IV) Cannula by: Distribution Channel (Value)
        • 7.2.3.1. Online Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Hospital Pharmacies
        • 7.2.3.4. Others
      • 7.2.4. Global Intravenous (IV) Cannula by: Size (Value)
        • 7.2.4.1. Orange (14G)
        • 7.2.4.2. Grey (16G)
        • 7.2.4.3. Green (18G)
        • 7.2.4.4. Pink (20G)
        • 7.2.4.5. Blue (22G)
        • 7.2.4.6. Yellow (24G)
        • 7.2.4.7. Violet (26G)
      • 7.2.5. Global Intravenous (IV) Cannula by: Material (Value)
        • 7.2.5.1. Plastic
        • 7.2.5.2. Metal
        • 7.2.5.3. Silicone
      • 7.2.6. Global Intravenous (IV) Cannula Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Intravenous (IV) Cannula (Volume)
      • 7.3.1. Global Intravenous (IV) Cannula by: Application (Volume)
        • 7.3.1.1. Medicine Administration
        • 7.3.1.2. Intravenous Fluid Administration
        • 7.3.1.3. Others
      • 7.3.2. Global Intravenous (IV) Cannula by: End-users (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Clinic
        • 7.3.2.3. Others
      • 7.3.3. Global Intravenous (IV) Cannula by: Distribution Channel (Volume)
        • 7.3.3.1. Online Pharmacies
        • 7.3.3.2. Retail Pharmacies
        • 7.3.3.3. Hospital Pharmacies
        • 7.3.3.4. Others
      • 7.3.4. Global Intravenous (IV) Cannula by: Size (Volume)
        • 7.3.4.1. Orange (14G)
        • 7.3.4.2. Grey (16G)
        • 7.3.4.3. Green (18G)
        • 7.3.4.4. Pink (20G)
        • 7.3.4.5. Blue (22G)
        • 7.3.4.6. Yellow (24G)
        • 7.3.4.7. Violet (26G)
      • 7.3.5. Global Intravenous (IV) Cannula by: Material (Volume)
        • 7.3.5.1. Plastic
        • 7.3.5.2. Metal
        • 7.3.5.3. Silicone
      • 7.3.6. Global Intravenous (IV) Cannula Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Intravenous (IV) Cannula (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Intravenous (IV) Cannula: by Application(USD Million)
  • Table 2. Intravenous (IV) Cannula Medicine Administration , by Region USD Million (2014-2019)
  • Table 3. Intravenous (IV) Cannula Intravenous Fluid Administration , by Region USD Million (2014-2019)
  • Table 4. Intravenous (IV) Cannula Others , by Region USD Million (2014-2019)
  • Table 5. Intravenous (IV) Cannula: by End-users(USD Million)
  • Table 6. Intravenous (IV) Cannula Hospital , by Region USD Million (2014-2019)
  • Table 7. Intravenous (IV) Cannula Clinic , by Region USD Million (2014-2019)
  • Table 8. Intravenous (IV) Cannula Others , by Region USD Million (2014-2019)
  • Table 9. Intravenous (IV) Cannula: by Distribution Channel(USD Million)
  • Table 10. Intravenous (IV) Cannula Online Pharmacies , by Region USD Million (2014-2019)
  • Table 11. Intravenous (IV) Cannula Retail Pharmacies , by Region USD Million (2014-2019)
  • Table 12. Intravenous (IV) Cannula Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 13. Intravenous (IV) Cannula Others , by Region USD Million (2014-2019)
  • Table 14. Intravenous (IV) Cannula: by Size(USD Million)
  • Table 15. Intravenous (IV) Cannula Orange (14G) , by Region USD Million (2014-2019)
  • Table 16. Intravenous (IV) Cannula Grey (16G) , by Region USD Million (2014-2019)
  • Table 17. Intravenous (IV) Cannula Green (18G) , by Region USD Million (2014-2019)
  • Table 18. Intravenous (IV) Cannula Pink (20G) , by Region USD Million (2014-2019)
  • Table 19. Intravenous (IV) Cannula Blue (22G) , by Region USD Million (2014-2019)
  • Table 20. Intravenous (IV) Cannula Yellow (24G) , by Region USD Million (2014-2019)
  • Table 21. Intravenous (IV) Cannula Violet (26G) , by Region USD Million (2014-2019)
  • Table 22. Intravenous (IV) Cannula: by Material(USD Million)
  • Table 23. Intravenous (IV) Cannula Plastic , by Region USD Million (2014-2019)
  • Table 24. Intravenous (IV) Cannula Metal , by Region USD Million (2014-2019)
  • Table 25. Intravenous (IV) Cannula Silicone , by Region USD Million (2014-2019)
  • Table 26. South America Intravenous (IV) Cannula, by Country USD Million (2014-2019)
  • Table 27. South America Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 28. South America Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 29. South America Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 30. South America Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 31. South America Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 32. Brazil Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 33. Brazil Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 34. Brazil Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 35. Brazil Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 36. Brazil Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 37. Argentina Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 38. Argentina Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 39. Argentina Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 40. Argentina Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 41. Argentina Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 42. Rest of South America Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 43. Rest of South America Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 44. Rest of South America Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 45. Rest of South America Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 46. Rest of South America Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 47. Asia Pacific Intravenous (IV) Cannula, by Country USD Million (2014-2019)
  • Table 48. Asia Pacific Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 49. Asia Pacific Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 50. Asia Pacific Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 51. Asia Pacific Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 52. Asia Pacific Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 53. China Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 54. China Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 55. China Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 56. China Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 57. China Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 58. Japan Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 59. Japan Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 60. Japan Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 61. Japan Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 62. Japan Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 63. India Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 64. India Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 65. India Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 66. India Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 67. India Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 68. South Korea Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 69. South Korea Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 70. South Korea Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 71. South Korea Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 72. South Korea Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 73. Taiwan Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 74. Taiwan Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 75. Taiwan Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 76. Taiwan Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 77. Taiwan Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 78. Australia Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 79. Australia Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 80. Australia Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 81. Australia Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 82. Australia Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 83. Rest of Asia-Pacific Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 84. Rest of Asia-Pacific Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 85. Rest of Asia-Pacific Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 86. Rest of Asia-Pacific Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 87. Rest of Asia-Pacific Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 88. Europe Intravenous (IV) Cannula, by Country USD Million (2014-2019)
  • Table 89. Europe Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 90. Europe Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 91. Europe Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 92. Europe Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 93. Europe Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 94. Germany Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 95. Germany Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 96. Germany Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 97. Germany Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 98. Germany Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 99. France Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 100. France Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 101. France Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 102. France Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 103. France Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 104. Italy Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 105. Italy Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 106. Italy Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 107. Italy Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 108. Italy Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 109. United Kingdom Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 110. United Kingdom Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 111. United Kingdom Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 112. United Kingdom Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 113. United Kingdom Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 114. Netherlands Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 115. Netherlands Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 116. Netherlands Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 117. Netherlands Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 118. Netherlands Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 119. Rest of Europe Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 120. Rest of Europe Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 121. Rest of Europe Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 122. Rest of Europe Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 123. Rest of Europe Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 124. MEA Intravenous (IV) Cannula, by Country USD Million (2014-2019)
  • Table 125. MEA Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 126. MEA Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 127. MEA Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 128. MEA Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 129. MEA Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 130. Middle East Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 131. Middle East Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 132. Middle East Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 133. Middle East Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 134. Middle East Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 135. Africa Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 136. Africa Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 137. Africa Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 138. Africa Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 139. Africa Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 140. North America Intravenous (IV) Cannula, by Country USD Million (2014-2019)
  • Table 141. North America Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 142. North America Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 143. North America Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 144. North America Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 145. North America Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 146. United States Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 147. United States Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 148. United States Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 149. United States Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 150. United States Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 151. Canada Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 152. Canada Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 153. Canada Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 154. Canada Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 155. Canada Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 156. Mexico Intravenous (IV) Cannula, by Application USD Million (2014-2019)
  • Table 157. Mexico Intravenous (IV) Cannula, by End-users USD Million (2014-2019)
  • Table 158. Mexico Intravenous (IV) Cannula, by Distribution Channel USD Million (2014-2019)
  • Table 159. Mexico Intravenous (IV) Cannula, by Size USD Million (2014-2019)
  • Table 160. Mexico Intravenous (IV) Cannula, by Material USD Million (2014-2019)
  • Table 161. Intravenous (IV) Cannula Sales: by Application(Y)
  • Table 162. Intravenous (IV) Cannula Sales Medicine Administration , by Region Y (2014-2019)
  • Table 163. Intravenous (IV) Cannula Sales Intravenous Fluid Administration , by Region Y (2014-2019)
  • Table 164. Intravenous (IV) Cannula Sales Others , by Region Y (2014-2019)
  • Table 165. Intravenous (IV) Cannula Sales: by End-users(Y)
  • Table 166. Intravenous (IV) Cannula Sales Hospital , by Region Y (2014-2019)
  • Table 167. Intravenous (IV) Cannula Sales Clinic , by Region Y (2014-2019)
  • Table 168. Intravenous (IV) Cannula Sales Others , by Region Y (2014-2019)
  • Table 169. Intravenous (IV) Cannula Sales: by Distribution Channel(Y)
  • Table 170. Intravenous (IV) Cannula Sales Online Pharmacies , by Region Y (2014-2019)
  • Table 171. Intravenous (IV) Cannula Sales Retail Pharmacies , by Region Y (2014-2019)
  • Table 172. Intravenous (IV) Cannula Sales Hospital Pharmacies , by Region Y (2014-2019)
  • Table 173. Intravenous (IV) Cannula Sales Others , by Region Y (2014-2019)
  • Table 174. Intravenous (IV) Cannula Sales: by Size(Y)
  • Table 175. Intravenous (IV) Cannula Sales Orange (14G) , by Region Y (2014-2019)
  • Table 176. Intravenous (IV) Cannula Sales Grey (16G) , by Region Y (2014-2019)
  • Table 177. Intravenous (IV) Cannula Sales Green (18G) , by Region Y (2014-2019)
  • Table 178. Intravenous (IV) Cannula Sales Pink (20G) , by Region Y (2014-2019)
  • Table 179. Intravenous (IV) Cannula Sales Blue (22G) , by Region Y (2014-2019)
  • Table 180. Intravenous (IV) Cannula Sales Yellow (24G) , by Region Y (2014-2019)
  • Table 181. Intravenous (IV) Cannula Sales Violet (26G) , by Region Y (2014-2019)
  • Table 182. Intravenous (IV) Cannula Sales: by Material(Y)
  • Table 183. Intravenous (IV) Cannula Sales Plastic , by Region Y (2014-2019)
  • Table 184. Intravenous (IV) Cannula Sales Metal , by Region Y (2014-2019)
  • Table 185. Intravenous (IV) Cannula Sales Silicone , by Region Y (2014-2019)
  • Table 186. South America Intravenous (IV) Cannula Sales, by Country Y (2014-2019)
  • Table 187. South America Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 188. South America Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 189. South America Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 190. South America Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 191. South America Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 192. Brazil Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 193. Brazil Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 194. Brazil Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 195. Brazil Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 196. Brazil Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 197. Argentina Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 198. Argentina Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 199. Argentina Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 200. Argentina Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 201. Argentina Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 202. Rest of South America Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 203. Rest of South America Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 204. Rest of South America Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 205. Rest of South America Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 206. Rest of South America Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 207. Asia Pacific Intravenous (IV) Cannula Sales, by Country Y (2014-2019)
  • Table 208. Asia Pacific Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 209. Asia Pacific Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 210. Asia Pacific Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 211. Asia Pacific Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 212. Asia Pacific Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 213. China Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 214. China Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 215. China Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 216. China Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 217. China Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 218. Japan Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 219. Japan Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 220. Japan Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 221. Japan Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 222. Japan Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 223. India Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 224. India Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 225. India Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 226. India Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 227. India Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 228. South Korea Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 229. South Korea Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 230. South Korea Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 231. South Korea Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 232. South Korea Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 233. Taiwan Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 234. Taiwan Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 235. Taiwan Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 236. Taiwan Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 237. Taiwan Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 238. Australia Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 239. Australia Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 240. Australia Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 241. Australia Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 242. Australia Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 243. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 244. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 245. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 246. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 247. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 248. Europe Intravenous (IV) Cannula Sales, by Country Y (2014-2019)
  • Table 249. Europe Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 250. Europe Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 251. Europe Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 252. Europe Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 253. Europe Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 254. Germany Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 255. Germany Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 256. Germany Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 257. Germany Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 258. Germany Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 259. France Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 260. France Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 261. France Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 262. France Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 263. France Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 264. Italy Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 265. Italy Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 266. Italy Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 267. Italy Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 268. Italy Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 269. United Kingdom Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 270. United Kingdom Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 271. United Kingdom Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 272. United Kingdom Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 273. United Kingdom Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 274. Netherlands Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 275. Netherlands Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 276. Netherlands Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 277. Netherlands Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 278. Netherlands Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 279. Rest of Europe Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 280. Rest of Europe Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 281. Rest of Europe Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 282. Rest of Europe Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 283. Rest of Europe Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 284. MEA Intravenous (IV) Cannula Sales, by Country Y (2014-2019)
  • Table 285. MEA Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 286. MEA Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 287. MEA Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 288. MEA Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 289. MEA Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 290. Middle East Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 291. Middle East Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 292. Middle East Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 293. Middle East Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 294. Middle East Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 295. Africa Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 296. Africa Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 297. Africa Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 298. Africa Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 299. Africa Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 300. North America Intravenous (IV) Cannula Sales, by Country Y (2014-2019)
  • Table 301. North America Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 302. North America Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 303. North America Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 304. North America Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 305. North America Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 306. United States Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 307. United States Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 308. United States Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 309. United States Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 310. United States Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 311. Canada Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 312. Canada Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 313. Canada Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 314. Canada Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 315. Canada Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 316. Mexico Intravenous (IV) Cannula Sales, by Application Y (2014-2019)
  • Table 317. Mexico Intravenous (IV) Cannula Sales, by End-users Y (2014-2019)
  • Table 318. Mexico Intravenous (IV) Cannula Sales, by Distribution Channel Y (2014-2019)
  • Table 319. Mexico Intravenous (IV) Cannula Sales, by Size Y (2014-2019)
  • Table 320. Mexico Intravenous (IV) Cannula Sales, by Material Y (2014-2019)
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Company Basic Information, Sales Area and Its Competitors
  • Table 331. Intravenous (IV) Cannula: by Application(USD Million)
  • Table 332. Intravenous (IV) Cannula Medicine Administration , by Region USD Million (2020-2025)
  • Table 333. Intravenous (IV) Cannula Intravenous Fluid Administration , by Region USD Million (2020-2025)
  • Table 334. Intravenous (IV) Cannula Others , by Region USD Million (2020-2025)
  • Table 335. Intravenous (IV) Cannula: by End-users(USD Million)
  • Table 336. Intravenous (IV) Cannula Hospital , by Region USD Million (2020-2025)
  • Table 337. Intravenous (IV) Cannula Clinic , by Region USD Million (2020-2025)
  • Table 338. Intravenous (IV) Cannula Others , by Region USD Million (2020-2025)
  • Table 339. Intravenous (IV) Cannula: by Distribution Channel(USD Million)
  • Table 340. Intravenous (IV) Cannula Online Pharmacies , by Region USD Million (2020-2025)
  • Table 341. Intravenous (IV) Cannula Retail Pharmacies , by Region USD Million (2020-2025)
  • Table 342. Intravenous (IV) Cannula Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 343. Intravenous (IV) Cannula Others , by Region USD Million (2020-2025)
  • Table 344. Intravenous (IV) Cannula: by Size(USD Million)
  • Table 345. Intravenous (IV) Cannula Orange (14G) , by Region USD Million (2020-2025)
  • Table 346. Intravenous (IV) Cannula Grey (16G) , by Region USD Million (2020-2025)
  • Table 347. Intravenous (IV) Cannula Green (18G) , by Region USD Million (2020-2025)
  • Table 348. Intravenous (IV) Cannula Pink (20G) , by Region USD Million (2020-2025)
  • Table 349. Intravenous (IV) Cannula Blue (22G) , by Region USD Million (2020-2025)
  • Table 350. Intravenous (IV) Cannula Yellow (24G) , by Region USD Million (2020-2025)
  • Table 351. Intravenous (IV) Cannula Violet (26G) , by Region USD Million (2020-2025)
  • Table 352. Intravenous (IV) Cannula: by Material(USD Million)
  • Table 353. Intravenous (IV) Cannula Plastic , by Region USD Million (2020-2025)
  • Table 354. Intravenous (IV) Cannula Metal , by Region USD Million (2020-2025)
  • Table 355. Intravenous (IV) Cannula Silicone , by Region USD Million (2020-2025)
  • Table 356. South America Intravenous (IV) Cannula, by Country USD Million (2020-2025)
  • Table 357. South America Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 358. South America Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 359. South America Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 360. South America Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 361. South America Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 362. Brazil Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 363. Brazil Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 364. Brazil Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 365. Brazil Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 366. Brazil Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 367. Argentina Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 368. Argentina Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 369. Argentina Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 370. Argentina Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 371. Argentina Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 372. Rest of South America Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 373. Rest of South America Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 374. Rest of South America Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 375. Rest of South America Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 376. Rest of South America Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 377. Asia Pacific Intravenous (IV) Cannula, by Country USD Million (2020-2025)
  • Table 378. Asia Pacific Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 379. Asia Pacific Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 380. Asia Pacific Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 381. Asia Pacific Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 382. Asia Pacific Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 383. China Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 384. China Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 385. China Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 386. China Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 387. China Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 388. Japan Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 389. Japan Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 390. Japan Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 391. Japan Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 392. Japan Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 393. India Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 394. India Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 395. India Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 396. India Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 397. India Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 398. South Korea Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 399. South Korea Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 400. South Korea Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 401. South Korea Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 402. South Korea Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 403. Taiwan Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 404. Taiwan Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 405. Taiwan Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 406. Taiwan Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 407. Taiwan Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 408. Australia Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 409. Australia Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 410. Australia Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 411. Australia Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 412. Australia Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 413. Rest of Asia-Pacific Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 414. Rest of Asia-Pacific Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 415. Rest of Asia-Pacific Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 416. Rest of Asia-Pacific Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 417. Rest of Asia-Pacific Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 418. Europe Intravenous (IV) Cannula, by Country USD Million (2020-2025)
  • Table 419. Europe Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 420. Europe Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 421. Europe Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 422. Europe Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 423. Europe Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 424. Germany Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 425. Germany Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 426. Germany Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 427. Germany Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 428. Germany Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 429. France Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 430. France Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 431. France Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 432. France Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 433. France Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 434. Italy Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 435. Italy Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 436. Italy Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 437. Italy Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 438. Italy Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 439. United Kingdom Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 440. United Kingdom Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 441. United Kingdom Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 442. United Kingdom Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 443. United Kingdom Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 444. Netherlands Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 445. Netherlands Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 446. Netherlands Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 447. Netherlands Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 448. Netherlands Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 449. Rest of Europe Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 450. Rest of Europe Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 451. Rest of Europe Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 452. Rest of Europe Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 453. Rest of Europe Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 454. MEA Intravenous (IV) Cannula, by Country USD Million (2020-2025)
  • Table 455. MEA Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 456. MEA Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 457. MEA Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 458. MEA Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 459. MEA Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 460. Middle East Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 461. Middle East Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 462. Middle East Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 463. Middle East Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 464. Middle East Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 465. Africa Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 466. Africa Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 467. Africa Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 468. Africa Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 469. Africa Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 470. North America Intravenous (IV) Cannula, by Country USD Million (2020-2025)
  • Table 471. North America Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 472. North America Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 473. North America Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 474. North America Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 475. North America Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 476. United States Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 477. United States Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 478. United States Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 479. United States Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 480. United States Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 481. Canada Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 482. Canada Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 483. Canada Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 484. Canada Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 485. Canada Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 486. Mexico Intravenous (IV) Cannula, by Application USD Million (2020-2025)
  • Table 487. Mexico Intravenous (IV) Cannula, by End-users USD Million (2020-2025)
  • Table 488. Mexico Intravenous (IV) Cannula, by Distribution Channel USD Million (2020-2025)
  • Table 489. Mexico Intravenous (IV) Cannula, by Size USD Million (2020-2025)
  • Table 490. Mexico Intravenous (IV) Cannula, by Material USD Million (2020-2025)
  • Table 491. Intravenous (IV) Cannula Sales: by Application(Y)
  • Table 492. Intravenous (IV) Cannula Sales Medicine Administration , by Region Y (2020-2025)
  • Table 493. Intravenous (IV) Cannula Sales Intravenous Fluid Administration , by Region Y (2020-2025)
  • Table 494. Intravenous (IV) Cannula Sales Others , by Region Y (2020-2025)
  • Table 495. Intravenous (IV) Cannula Sales: by End-users(Y)
  • Table 496. Intravenous (IV) Cannula Sales Hospital , by Region Y (2020-2025)
  • Table 497. Intravenous (IV) Cannula Sales Clinic , by Region Y (2020-2025)
  • Table 498. Intravenous (IV) Cannula Sales Others , by Region Y (2020-2025)
  • Table 499. Intravenous (IV) Cannula Sales: by Distribution Channel(Y)
  • Table 500. Intravenous (IV) Cannula Sales Online Pharmacies , by Region Y (2020-2025)
  • Table 501. Intravenous (IV) Cannula Sales Retail Pharmacies , by Region Y (2020-2025)
  • Table 502. Intravenous (IV) Cannula Sales Hospital Pharmacies , by Region Y (2020-2025)
  • Table 503. Intravenous (IV) Cannula Sales Others , by Region Y (2020-2025)
  • Table 504. Intravenous (IV) Cannula Sales: by Size(Y)
  • Table 505. Intravenous (IV) Cannula Sales Orange (14G) , by Region Y (2020-2025)
  • Table 506. Intravenous (IV) Cannula Sales Grey (16G) , by Region Y (2020-2025)
  • Table 507. Intravenous (IV) Cannula Sales Green (18G) , by Region Y (2020-2025)
  • Table 508. Intravenous (IV) Cannula Sales Pink (20G) , by Region Y (2020-2025)
  • Table 509. Intravenous (IV) Cannula Sales Blue (22G) , by Region Y (2020-2025)
  • Table 510. Intravenous (IV) Cannula Sales Yellow (24G) , by Region Y (2020-2025)
  • Table 511. Intravenous (IV) Cannula Sales Violet (26G) , by Region Y (2020-2025)
  • Table 512. Intravenous (IV) Cannula Sales: by Material(Y)
  • Table 513. Intravenous (IV) Cannula Sales Plastic , by Region Y (2020-2025)
  • Table 514. Intravenous (IV) Cannula Sales Metal , by Region Y (2020-2025)
  • Table 515. Intravenous (IV) Cannula Sales Silicone , by Region Y (2020-2025)
  • Table 516. South America Intravenous (IV) Cannula Sales, by Country Y (2020-2025)
  • Table 517. South America Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 518. South America Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 519. South America Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 520. South America Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 521. South America Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 522. Brazil Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 523. Brazil Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 524. Brazil Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 525. Brazil Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 526. Brazil Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 527. Argentina Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 528. Argentina Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 529. Argentina Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 530. Argentina Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 531. Argentina Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 532. Rest of South America Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 533. Rest of South America Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 534. Rest of South America Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 535. Rest of South America Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 536. Rest of South America Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 537. Asia Pacific Intravenous (IV) Cannula Sales, by Country Y (2020-2025)
  • Table 538. Asia Pacific Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 539. Asia Pacific Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 540. Asia Pacific Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 541. Asia Pacific Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 542. Asia Pacific Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 543. China Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 544. China Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 545. China Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 546. China Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 547. China Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 548. Japan Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 549. Japan Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 550. Japan Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 551. Japan Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 552. Japan Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 553. India Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 554. India Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 555. India Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 556. India Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 557. India Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 558. South Korea Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 559. South Korea Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 560. South Korea Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 561. South Korea Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 562. South Korea Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 563. Taiwan Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 564. Taiwan Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 565. Taiwan Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 566. Taiwan Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 567. Taiwan Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 568. Australia Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 569. Australia Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 570. Australia Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 571. Australia Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 572. Australia Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 573. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 574. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 575. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 576. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 577. Rest of Asia-Pacific Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 578. Europe Intravenous (IV) Cannula Sales, by Country Y (2020-2025)
  • Table 579. Europe Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 580. Europe Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 581. Europe Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 582. Europe Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 583. Europe Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 584. Germany Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 585. Germany Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 586. Germany Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 587. Germany Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 588. Germany Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 589. France Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 590. France Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 591. France Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 592. France Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 593. France Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 594. Italy Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 595. Italy Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 596. Italy Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 597. Italy Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 598. Italy Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 599. United Kingdom Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 600. United Kingdom Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 601. United Kingdom Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 602. United Kingdom Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 603. United Kingdom Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 604. Netherlands Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 605. Netherlands Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 606. Netherlands Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 607. Netherlands Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 608. Netherlands Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 609. Rest of Europe Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 610. Rest of Europe Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 611. Rest of Europe Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 612. Rest of Europe Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 613. Rest of Europe Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 614. MEA Intravenous (IV) Cannula Sales, by Country Y (2020-2025)
  • Table 615. MEA Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 616. MEA Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 617. MEA Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 618. MEA Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 619. MEA Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 620. Middle East Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 621. Middle East Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 622. Middle East Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 623. Middle East Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 624. Middle East Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 625. Africa Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 626. Africa Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 627. Africa Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 628. Africa Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 629. Africa Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 630. North America Intravenous (IV) Cannula Sales, by Country Y (2020-2025)
  • Table 631. North America Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 632. North America Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 633. North America Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 634. North America Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 635. North America Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 636. United States Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 637. United States Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 638. United States Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 639. United States Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 640. United States Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 641. Canada Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 642. Canada Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 643. Canada Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 644. Canada Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 645. Canada Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 646. Mexico Intravenous (IV) Cannula Sales, by Application Y (2020-2025)
  • Table 647. Mexico Intravenous (IV) Cannula Sales, by End-users Y (2020-2025)
  • Table 648. Mexico Intravenous (IV) Cannula Sales, by Distribution Channel Y (2020-2025)
  • Table 649. Mexico Intravenous (IV) Cannula Sales, by Size Y (2020-2025)
  • Table 650. Mexico Intravenous (IV) Cannula Sales, by Material Y (2020-2025)
  • Table 651. Research Programs/Design for This Report
  • Table 652. Key Data Information from Secondary Sources
  • Table 653. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Intravenous (IV) Cannula: by Application USD Million (2014-2019)
  • Figure 5. Global Intravenous (IV) Cannula: by End-users USD Million (2014-2019)
  • Figure 6. Global Intravenous (IV) Cannula: by Distribution Channel USD Million (2014-2019)
  • Figure 7. Global Intravenous (IV) Cannula: by Size USD Million (2014-2019)
  • Figure 8. Global Intravenous (IV) Cannula: by Material USD Million (2014-2019)
  • Figure 9. South America Intravenous (IV) Cannula Share (%), by Country
  • Figure 10. Asia Pacific Intravenous (IV) Cannula Share (%), by Country
  • Figure 11. Europe Intravenous (IV) Cannula Share (%), by Country
  • Figure 12. MEA Intravenous (IV) Cannula Share (%), by Country
  • Figure 13. North America Intravenous (IV) Cannula Share (%), by Country
  • Figure 14. Global Intravenous (IV) Cannula: by Application Y (2014-2019)
  • Figure 15. Global Intravenous (IV) Cannula: by End-users Y (2014-2019)
  • Figure 16. Global Intravenous (IV) Cannula: by Distribution Channel Y (2014-2019)
  • Figure 17. Global Intravenous (IV) Cannula: by Size Y (2014-2019)
  • Figure 18. Global Intravenous (IV) Cannula: by Material Y (2014-2019)
  • Figure 19. South America Intravenous (IV) Cannula Share (%), by Country
  • Figure 20. Asia Pacific Intravenous (IV) Cannula Share (%), by Country
  • Figure 21. Europe Intravenous (IV) Cannula Share (%), by Country
  • Figure 22. MEA Intravenous (IV) Cannula Share (%), by Country
  • Figure 23. North America Intravenous (IV) Cannula Share (%), by Country
  • Figure 24. Global Intravenous (IV) Cannula share by Players 2019 (%)
  • Figure 25. Global Intravenous (IV) Cannula share by Players (Top 3) 2019(%)
  • Figure 26. Global Intravenous (IV) Cannula share by Players (Top 5) 2019(%)
  • Figure 27. BCG Matrix for key Companies
  • Figure 28. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Boston Scientific Corporation (United States) Revenue: by Geography 2019
  • Figure 30. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 31. Teleflex Incorporated (United States) Revenue: by Geography 2019
  • Figure 32. CONMED Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. CONMED Corporation (United States) Revenue: by Geography 2019
  • Figure 34. Sorin Group (Italy) Revenue, Net Income and Gross profit
  • Figure 35. Sorin Group (Italy) Revenue: by Geography 2019
  • Figure 36. Edward Lifescience (United States) Revenue, Net Income and Gross profit
  • Figure 37. Edward Lifescience (United States) Revenue: by Geography 2019
  • Figure 38. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 39. Medtronic plc (Ireland) Revenue: by Geography 2019
  • Figure 40. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 41. Terumo Corporation (Japan) Revenue: by Geography 2019
  • Figure 42. Smith & Nephew plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 43. Smith & Nephew plc (United Kingdom) Revenue: by Geography 2019
  • Figure 44. Smiths Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 45. Smiths Medical, Inc. (United States) Revenue: by Geography 2019
  • Figure 46. MAQUET Holding B.V. & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 47. MAQUET Holding B.V. & Co. KG (Germany) Revenue: by Geography 2019
  • Figure 48. Global Intravenous (IV) Cannula: by Application USD Million (2020-2025)
  • Figure 49. Global Intravenous (IV) Cannula: by End-users USD Million (2020-2025)
  • Figure 50. Global Intravenous (IV) Cannula: by Distribution Channel USD Million (2020-2025)
  • Figure 51. Global Intravenous (IV) Cannula: by Size USD Million (2020-2025)
  • Figure 52. Global Intravenous (IV) Cannula: by Material USD Million (2020-2025)
  • Figure 53. South America Intravenous (IV) Cannula Share (%), by Country
  • Figure 54. Asia Pacific Intravenous (IV) Cannula Share (%), by Country
  • Figure 55. Europe Intravenous (IV) Cannula Share (%), by Country
  • Figure 56. MEA Intravenous (IV) Cannula Share (%), by Country
  • Figure 57. North America Intravenous (IV) Cannula Share (%), by Country
  • Figure 58. Global Intravenous (IV) Cannula: by Application Y (2020-2025)
  • Figure 59. Global Intravenous (IV) Cannula: by End-users Y (2020-2025)
  • Figure 60. Global Intravenous (IV) Cannula: by Distribution Channel Y (2020-2025)
  • Figure 61. Global Intravenous (IV) Cannula: by Size Y (2020-2025)
  • Figure 62. Global Intravenous (IV) Cannula: by Material Y (2020-2025)
  • Figure 63. South America Intravenous (IV) Cannula Share (%), by Country
  • Figure 64. Asia Pacific Intravenous (IV) Cannula Share (%), by Country
  • Figure 65. Europe Intravenous (IV) Cannula Share (%), by Country
  • Figure 66. MEA Intravenous (IV) Cannula Share (%), by Country
  • Figure 67. North America Intravenous (IV) Cannula Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Boston Scientific Corporation (United States)
  • Teleflex Incorporated (United States)
  • CONMED Corporation (United States)
  • Sorin Group (Italy)
  • Edward Lifescience (United States)
  • Medtronic plc (Ireland)
  • Terumo Corporation (Japan)
  • Smith & Nephew plc (United Kingdom)
  • Smiths Medical, Inc. (United States)
  • MAQUET Holding B.V. & Co. KG (Germany)
Additional players considered in the study are as follows:
Armstrong Medical Ltd (United Kingdom) , Omex Medical Technology (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation